Impressive Adjusted EBITDA Margin Expansion and Cash Generation Full Year 2025 Guidance Reaffirmed BELO HORIZONTE, Brazil–(BUSINESS WIRE)–Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and six-month period, which ended June 30, … [Read more…]
Executing on Commercial Readiness Plans in Anticipation of FDA 510(k) Clearance for Groundbreaking 12-lead Electrocardiogram (ECG) Synthesis Software Engaged in Ongoing Productive Discussions with FDA Related to the 510(k) Application Increased Business Development Resources to Match Inbound Interest from Industry Partners Management to Host Webcast and Conference Call Today at 4:30 p.m. ET SANTA CLARA, … [Read more…]
Flatiron’s 2025 WCLC research showcases the power of multimodal real-world oncology data and innovative AI-data extraction methodologies to generate actionable evidence for people with lung cancer NEW YORK–(BUSINESS WIRE)–Flatiron Health today announced eight abstracts leveraging its high-quality multimodal data have been accepted for poster presentation and e-Poster presentation at the IASLC 2025 World Conference on … [Read more…]
NEW YORK–(BUSINESS WIRE)–CheckedUp, the fastest-growing digital Point of Care company transforming patient and provider engagement, today announced its fourth appearance on the 2025 Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America. The list provides a data-driven snapshot of the most successful companies within the economy’s most dynamic segment—its independent, … [Read more…]
AUSTIN, Texas–(BUSINESS WIRE)–Wenzel Spine, Inc., a medical device company pioneering minimally invasive surgical and analytic solutions for spinal disorders, today announced completion of first cases and the U.S. limited commercial launch of its novel panaSIa™ Expandable SI Fusion System. panaSIa is the first expandable sacroiliac (SI) fusion implant cleared by the FDA and represents a … [Read more…]
Groundbreaking research by Professor Richard Costello leads to innovative digital health platform DUBLIN–(BUSINESS WIRE)–Phyxiom, a pioneering digital healthcare company, today announced its official launch, bringing transformative technology developed through extensive clinical research led by globally recognised respiratory specialist, Professor Richard Costello (RCSI University of Medicine and Health Sciences and Beaumont Hospital). Built upon groundbreaking studies … [Read more…]
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–CareTrust REIT, Inc. (NYSE: CTRE) (“CareTrust REIT” or the “Company”) announced that, subject to market and other conditions, it intends to offer to sell 15,500,000 shares of its common stock in an underwritten public offering. The Company also intends to grant the underwriters a 30-day option to purchase up to an additional … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Tenosynovitis Market – A Global and Regional Analysis: Focus on Country and Region – Analysis and Forecast, 2025-2035” report has been added to ResearchAndMarkets.com’s offering. The global Tenosynovitis market is highly competitive, with several key players actively driving innovation, advancing research, and expanding treatment options. Companies such as Pfizer Inc., AbbVie Inc., Johnson … [Read more…]
The new system, designed to improve reverse shoulder arthroplasty for proximal humeral fractures, includes patented technology that helps reduce surgical complexity and drive clinical confidence NAPLES, Fla.–(BUSINESS WIRE)–Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology leader focused on shoulder arthroplasty, the fastest growing segment in the orthopedics market, announced today the full commercial release of … [Read more…]
Ad hoc announcement pursuant to Art. 53 LR ENIGMA-TRS 1 is an international, one-year, double-blind, placebo-controlled Phase III study in at least 600 patients; 12-week study results expected in Q4 2026 Evenamide, a first-in-class glutamate modulator, has the potential to be the first add-on therapy for TRS patients and for poorly responding patients with schizophrenia … [Read more…]
